AzTrials
AzTrials

Randomized Controlled TrialNCT03593135

Effect of Apple Cider Vinegar in Type 2 Diabetics

A study testing Apple Cider Vinegar and tablet Tagipmet (Metformin + Sitagliptin group) and Water with Apple Cider vinegar flavor and tablet Tagipmet (Metformin + Sitagliptin group) in people with Randomized Controlled Trial and Diabetes Mellitus, run by Sheikh Zayed Federal Postgraduate Medical Institute at 1 site in Pakistan.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Background: apple cider vinegar is natural traditional health beneficial nutraceutical used for many aliments. Diabetes mellitus (DM) has been considered a globally major health problem and posing health burden on families and health system. Read more about this study

Who is it for?
Ages 30 to 60 years
What is being tested?
Apple Cider Vinegar and tablet Tagipmet (Metformin + Sitagliptin group) and Water with Apple Cider vinegar flavor and tablet Tagipmet (Metformin + Sitagliptin group)
Type of treatment
Pill or oral medicine
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
126 participants
Where
1 sitePakistan
Study dates
15 Jul 2017to 14 Nov 2017
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 30 to 60 years
  • All sexes
  • No healthy volunteers
  • Adult

Who may be able to join

  • Adult patients having uncontrolled type 2 diabetes with raised HbA1c levels.
  • Both gender.
  • Age ranging from 30-60 years.
  • All having body mass index between 20-30.
  • Non alcoholics.
  • Non smoker.
  • All were on standard medical therapy for diabetes (including Metformin + Sitagliptin group).

Who cannot join

  • Patients suffering from known chronic renal disease.
  • History of cardiovascular diseases like stroke, ischemic heart disease.
  • Known allergy to vinegar.
  • intolerance to vinegar, reported by the patient or relative.
  • Any kind of acute infection were excluded from study.

Trial locations and contacts

1 site in 1 country.

Pakistan1 site
  • Shaikh Zayed Medical Complex

    Lahore, Punjab Province, 54000

Other trials in Pakistan

About this study

Official title: Effect of Apple Cider Vinegar in Type 2 Diabetic Patients With Poor Glycemic Control: a Randomized Controlled Design

Background: apple cider vinegar is natural traditional health beneficial nutraceutical used for many aliments. Diabetes mellitus (DM) has been considered a globally major health problem and posing health burden on families and health system. Diabetes is associated with life style that leading to reduce physical activities and increased in obesity. For development of diabetes the known mechanism are endocrine disorders which cause impaired insulin secretion, hepatic glucose over production and insulin resistance.

Objective: The aim of current randomized controlled trial was to investigate the effect of apple cider vinegar on glycemic control and biochemical parameters in type 2 diabetic patients with poor glycaemic control.

Read more

Material \& Methods: 110 type 2 diabetic patients according to inclusion criteria were selected and divided into two groups. Interventional group was given 15 ml apple cider vinegar in 200ml water during meal at night time for 3 months. Before and after HbA1C, fasting lipid profile, fasting blood sugar, anthropometrics and dietary changes were assessed and analyzed using IBM SPSS version 20 through paired sample T-test where needed.

.

Read the detailed description

A study conducted in pre-diabetic healthy individuals showed significant (p=0.05) reduction in HbA1C, in apple cider vinegar group . Many RCTs of human and animals showed hypolipidemic effects of ACV. Anti obesity effect of apple cider vinegar also found in many studies. There is still lot of work going on and this present study is conducted with an objective to measure the effect of apple cider vinegar on HbA1c, fasting blood glucose, fasting lipid profile and body weight.

METHOD:

STUDY DESIGN AND SETTING

This study was a single-blind, randomized-controlled placebo trial. Trial period was three months from August 15, to November 15, 2017. This study was conducted at a 1050 beded tertiary care, teaching hospital of Lahore, Pakistan. This hospital has high diabetics out-patient turnover as being a reputable center in management of diabetes.

PARTICIPANTS:

Adult patients having type 2 diabetes, of both genders with age range from 30-60 years were included. All having BMI between 20-30, non smoker and non alcoholics and all were on standard medical therapy for diabetes (including Metformin + Sitagliptin group). Patients suffering from known chronic renal disease and history of cardiovascular diseases like stroke, ischemic heart disease and known allergy or intolerance to vinegar, reported by the patient or relative and any kind of acute infection were excluded from study.

The sample size of 110 (55 in each group) was estimated by using 95% confidence level,80% power with expected mean change in HbA1c 0.53% and 0.11% for cases treated with apple vinegar and placebo respectively with a SD of 0.77% (by using power + precision 3.0 software). Assuming a 12.6% non-response rate, RCT started with 126 patients, 63 patients in each group. 16 patients were lost to follow up during study period, so finally statistical analysis was done on 110 patients 55 in each group.

DEPENDENT VARIABLES: A structured questionnaire was used for collecting respondents' information. Blood samples were taken for biochemical test (HbA1c, lipid profile and fasting blood glucose) and anthropometrics measurements were done.

Anthropometric measurements: Height was measured in centimeter to nearest 0.1 cm by using standard stadiometer before intervention and weight was measured in kilogram to nearest 100 g with wearing light cloth by using a calibrated weighing scale machine before and after intervention. Hip/waist ratio and mid upper arm were measured with measuring tape in centimeter to nearest 0.1cm. The BMI of study participants were classified as underweight, normal, over weight and obese according to WHO criteria weight was measured as weight (kg)/height (cm)2.

Biochemical assessments:

At before start of intervention and after intervention 5ml venous blood sample was taken with 12hours fasting for biochemical assessments including blood sugar fasting, HbA1C (glycated hemoglobin), total cholesterol, low density lipoprotein, high density lipoprotein and triglyceride were evaluated.

CONFOUNDING VARIABLES:

Dietary intake:

Diet of study participants can influence and confound the intervention during study period so it was assessed through food frequency questionnaire. Food frequency was filled two times before and after intervention to measure change during study period which can actually confound the effect of apple cider vinegar. The food frequency questionnaire was structured according to Pakistan's cultural food preferences and choices. FFQs contained methods of food preparation, frequency per day and per week and portion size/ amount of food consumed in categories from never, monthly to 1-7 days in a week. Food exchange lists were used to assess the portion size of food. FFQ composed of cereal group, fruits, vegetable, meat, milk, fat/oil, snacks and beverages.

INDEPENDENT VARIABLE/ INTERVENTION: This selected nutraceutical (Apple cider vinegar) was given for three months. Apple cider vinegar was provided to patients and instructions were given to all participants about the uses of apple cider vinegar and strictly follow the prescribed nutraceutical given as per following schedule; Group I: Intervention group Intervention group taking their diet according to their original meal pattern only dietary guideline were given regarding high glycaemic and low glycaemic diet. Medical treatments continued (including Metformin + Sitagliptin group). 15ml apple cider vinegar (American garden organic vinegar) (containing 5% acetic acid) mixed in 200ml water during meal at night time was prescribed.

Group II: comparison group Control group also taking their diet according to their original meal pattern only dietary guideline were given regarding high glycaemic and low glycaemic diet. Medical treatment continued (including Metformin + Sitagliptin group). 15ml apple cider vinegar (flavor of ACV in plan water was used as placebo) mixed in 200ml plain water during meal at night time.

Statistical analysis:

Descriptive statistical analysis was done for demographic profile, categorical and numerical variables by measuring frequency, percentage, mean and standard deviation of all samples. Paired sample T test was used for anthropometrics measurement and biochemical assessment for two time assessment before and after intervention. Independent sample t-test was used for comparison between groups. Where needed ANOVA was also applied. McNemar statistical test was used to assess the food frequency questionnaire before and after intervention.

Ethical considerations:

Proper ethical clearance was obtained from Institutional Review Board of Shaikh Zayed Medical Complex before starting the trial.

Being tested
Apple Cider Vinegar and tablet Tagipmet (Metformin + Sitagliptin group), Water with Apple Cider vinegar flavor and tablet Tagipmet (Metformin + Sitagliptin group)
Keywords
vinegar, diabetes, hyperglycemia, hypercholesterolemia, nutraceutical
Medical subject headings
Diabetes Mellitus, Hyperglycemia, Hypercholesterolemia

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Apple Cider Vinegar and tablet Tagipmet (Metformin + Sitagliptin group)Dietary supplement

    Also called intervention

    15ml apple cider vinegar (American garden organic vinegar) (containing 5% acetic acid) mixed in 200ml water during meal at night time, for 3 months and tablet Tagipmet 50mg/1000mg (Metformin + Sitagliptin group) twice a day. NOTE medical treatment is our inclusion criteria.

  • Water with Apple Cider vinegar flavor and tablet Tagipmet (Metformin + Sitagliptin group)Other

    Also called Placebo

    Flavor of apple cider vinegar in 200 ml water is added and given to have a placebo effect and tablet Tagipmet 50mg/1000mg (Metformin + Sitagliptin group) twice a day. NOTE medical treatment is our inclusion criteria.

Study groups in NCT03593135
Study groupRoleWhat they receive
Intervention groupExperimentalIntervention group taking their diet according to their original meal pattern only dietary guideline were given regarding high glycaemic and low glycaemic diet. Medical treatments continued (including tablet Tagipment 50mg/1000mg twice a day)(Metformin + Sitagliptin group). 15ml apple cider vinegar (American garden organic vinegar) (containing 5% acetic acid) mixed in 200ml water during meal at night time was prescribed.
Receives: Dietary Supplement: Apple Cider Vinegar and tablet Tagipmet (Metformin + Sitagliptin group)
Comparison groupPlacebo comparatorControl group also taking their diet according to their original meal pattern only dietary guideline were given regarding high glycaemic and low glycaemic diet. Medical treatment continued (including tablet Tagipmet 50mg/1000mg twice a day)( Metformin + Sitagliptin group). Flavor of apple cider vinegar used as placebo, mixed in 200ml plain water during meal at night time.
Receives: Other: Water with Apple Cider vinegar flavor and tablet Tagipmet (Metformin + Sitagliptin group)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. HbA1c (Glycosylated Hemoglobin)

    Before start of intervention and after intervention 5ml venous blood sample was taken for biochemical analysis of HbA1C (glycosylated hemoglobin) in sterilized tubes,commercial kits of Siemens for Dimmension RxL used and the HbA1C measuement is based on a turbidimetric inhibition immunoassay (TINIA) priniciple.

    Measured: 3 months

Secondary outcomes (2)
  1. blood sugar fasting

    Before start of intervention and after intervention 5ml venous blood sample was taken with 12 hours fasting for biochemical analysis of blood sugar fasting in sterilized dray tubes,commercial kits of Siemens for Dimmension XL and photometric methods for analysis was used.

    Measured: 3 months

  2. fasting lipid profile

    Before start of intervention and after intervention 5ml venous blood sample was taken with 12 hours fasting for biochemical analysis of fasting lipid profile commercial kits of Rodex for Dimmension Rxl and photometric methods for analysis were used.

    Measured: 3 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted19 Jul 2018
  2. Study start15 Jul 2017
  3. Primary completion14 Nov 2017
  4. Study completion14 Nov 2017

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
Randomized controlled trial
Masking
Single blind
Who is masked
Participant
Enrolment
126 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03593135
Sponsor's protocol ID
1481
Status last verified
Jul 2018
First submitted
24 Jun 2018
Last updated
19 Jul 2018
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Clarke P. Seat belts. Lancet. 1977 May 28;1(8022):1155. doi: 10.1016/s0140-6736(77)92414-x. No abstract available.

    PubMed 68254

Questions about this trial

What is this clinical trial studying?

A study testing Apple Cider Vinegar and tablet Tagipmet (Metformin + Sitagliptin group) and Water with Apple Cider vinegar flavor and tablet Tagipmet (Metformin + Sitagliptin group) in people with Randomized Controlled Trial and Diabetes Mellitus, run by Sheikh Zayed Federal Postgraduate Medical Institute at 1 site in Pakistan.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 7 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 19 Jul 2018. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Pakistan. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

HbA1c (Glycosylated Hemoglobin) (time frame: 3 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03593135, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 19 Jul 2018.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in